Shoreline Biosciences (Venture)
Funding Details
Awarder
Inbox
Date Award
November 2, 2021
Vertical
Biotechnology
Funding Amount
$140,000,000
Company Info
Organizations Involved
Kite, BeiGene
Founders
Kleanthis G. Xanthopoulos, Ph.D.
Market
Cancer Immunotherapy
Location
San Diego, California, USA
Coinvestors
Ally Bridge Group, BeiGene, Boxer Capital, BVF Partners, Commodore Capital, Cormorant Asset Management, Eventide Asset Management, Kingdon Capital, NS Investment, Piper Heartland Healthcare Capital, Superstring
Company Description

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.